Your browser doesn't support javascript.
loading
Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer.
Xu, Jin-Zhi; Wang, Wen-Quan; Zhang, Shi-Rong; Xu, Hua-Xiang; Wu, Chun-Tao; Qi, Zi-Hao; Gao, He-Li; Li, Shuo; Ni, Quan-Xing; Yu, Xian-Jun; Liu, Liang.
Afiliação
  • Xu JZ; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Wang WQ; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Zhang SR; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Xu HX; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wu CT; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Qi ZH; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Gao HL; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Ni QX; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Yu XJ; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Liu L; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Curr Med Chem ; 26(40): 7196-7211, 2019.
Article em En | MEDLINE | ID: mdl-29651946

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article